Table 4.
Diagnosis | ||||
---|---|---|---|---|
Needle biopsy | FEA | FEA | FEA + ADH | ADH |
Surgical excision | FEA | Carcinoma | ||
Kunju and Kleer4 | 0% (0/14) | 21% (3/14) | 11% (4/38) | 38% (3/8) |
Martel et al.16 | 0% (0/5) | 0% (0/5) | – | – |
Chivukula et al.6 | 0% (0/35) | 14% (5/35) | 16% (31/189) | 11% (5/45) |
Senetta et al.18 | (?/36) | 0% (0/36) | – | – |
Piubello et al.5 | 50% (10/20) | 0% (0/20) | 30% (3/10) | – |
de Mascarel et al.9 | (?/24) | 0% (0/24) | – | 64% (32/50) |
Rakha et al.17 |
0% (0/7) | 14% (1/7) | 29% (2/7) | 40% (6/15) |
Rajan et al.11 |
(?/37) | 19% (7/37) | 29% (5/17) | 53% (17/32) |
Lavoué V et al.10 | 23% (14/60) | 13% (8/60) | – | – |
Our study (2012) | 0% (0/8) | 13% (1/8) | 70% (7/10) | 55% (17/44) |
ADH, atypical ductal hyperplasia; FEA, flat epithelial atypia.